Cefpodoxime Proxetil - CAS 87239-81-4
Catalog number:
87239-81-4
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C21H27N5O9S2
Molecular Weight:
557.60
COA:
Inquire
Targets:
Antibacterial
Description:
Cefpodoxime Proxetil is a third generation cephalosporin, ester prodrug of the active free acid metabolite Cefpodoxime. Cefpodoxime is active against most Gram-positive and Gram-negative organisms. It can be used to treat acute otitis media, pharyngitis, sinusitis, and gonorrhea.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
White to Pale Yellow Solid
Synonyms:
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester; Antibiotic CS 807; Banan; CS 807; Cefodox; Cefoprox; Cephpodoxime Proxetil; Cepodem; Orelox; Otreon; RU 51807; U 76252; Vantin;
Solubility:
DMSO (Slightly), Methanol (Slightly)
Storage:
-20℃ Freezer
MSDS:
Inquire
Application:
Antibacterial agent
Quality Standard:
USP
Shelf Life:
2 month in rt, long tim
Quantity:
Milligrams-Grams
Boiling Point:
No Data Available
Melting Point:
>92℃ (dec.)
Density:
1.58 g/cm3
InChIKey:
LTINZAODLRIQIX-FBXRGJNPSA-N
InChI:
InChI=1S/C21H27N5O9S2/c1-9(2)33-21(30)35-10(3)34-19(29)15-11(6-31-4)7-36-18-14(17(28)26(15)18)24-16(27)13(25-32-5)12-8-37-20(22)23-12/h8-10,14,18H,6-7H2,1-5H3,(H2,22,23)(H,24,27)/b25-13-/t10?,14-,18-/m1/s1
Canonical SMILES:
CC(C)OC(=O)OC(C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CSC(=N3)N)COC
Current Developer:
Originator Pfizer
1.New valid spectrofluorimetric method for determination of selected cephalosporins in different pharmaceutical formulations using safranin as fluorophore.
Derayea SM1, Ahmed HM2, Abdelmageed OH3, Haredy AM1. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Jan 15;153:655-60. doi: 10.1016/j.saa.2015.10.001. Epub 2015 Oct 9.
A new validated spectrofluorimetric method has been developed for the determination of some cephalosporins namely; cefepime, cefaclor, cefadroxil, cefpodoxime and cefexime. The method was based on the reaction of these drugs with safranin in slightly alkaline medium (pH 8.0), to form ion-association complexes. The fluorescent products were extracted into chloroform and their fluorescence intensities were measured at 544-565 nm after excitation at 518-524 nm. The reaction conditions influencing the product formation and stability were investigated and optimized. The relative fluorescence intensity was proportional to the drug concentration in the linear ranges of 0.15-1.35, 0.35-1.25, 0.35-1.25, 0.20-1.44 and 0.20-1.25 μg/mL for cefepime, cefaclor, cefadroxil, cefpodoxime proxetil and cefexime, respectively. The detection limits were 40, 100, 100, 60 and 70 ng/mL, respectively. The performance of the developed method was evaluated in terms of Student's t-test and variance ratio F-test to find out the significance of proposed methods over the reference spectrophotometric method.
2.Natural gum as mucoadhesive controlled release carriers: evaluation of cefpodoxime proxetil by D-optimal design technique.
Patil SH1, Talele GS. Drug Deliv. 2014 Mar;21(2):118-29. doi: 10.3109/10717544.2013.834416. Epub 2013 Sep 13.
The present study deals with the development of mucoadhesive controlled release tablets of Cefpodoxime Proxetil to increase the gastric residence time and thus prolong drug release, reduce dosing frequency and improve oral bioavailability. Tablets were prepared using sodium alginate and karaya gum, a natural polymer, with a synthetic polymer hydroxypropylmethylcellulose (K100LV) and Karaya gum with HPMC K100LV in various ratios to optimize the drug release profile using D-Optimal technique. Pre- and post-compression parameters of tablets prepared with various formulations (S1-S9, C1-C9) were evaluated. The FTIR and DSC studies revealed that no physiochemical interaction between excipients and drug. The formulation S7 showed prolonged drug release, and the mechanism of drug release from the optimized formulation was confirmed using the Korsmeyer-Peppas model to be non-Fickian release transport and n value was found 0.605 indicating both diffusion and erosion mechanism from these natural gums.
3.Highly sensitive and selective high-performance liquid chromatography method for bioequivalence study of cefpodoxime proxetil in rabbit plasma via fluorescence labeling of its active metabolite.
Ahmed S1, Abdel-Wadood HM, Mohamed NA. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:34-40. doi: 10.1016/j.jchromb.2013.06.036. Epub 2013 Jul 5.
Cefpodoxime proxetil (CFP), a broad-spectrum third-generation cephalosporin, has been used most widely in the treatment of respiratory and urinary tract infections. For bioequivalence study of CFP in rabbit plasma, it was necessary to develop a highly sensitive and selective high-performance liquid chromatographic (HPLC) method with fluorescence (FL) detection. The pre-column labeling of cefpodoxime acid (CFA) (active metabolite) with an efficient benzofurazan type fluorogenic reagent, 4-N,N-dimethyl aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole (DBD-F) was carried out in the present study in 100mM borate buffer (pH=8.5) at 50°C for 15min. The obtained fluorescent products were separated on C18 column with an isocratic elution of the mobile phase, which consists of 10mM phosphate buffer (pH=3.5)/CH3CN (70:30, v/v). The fluorescent product (DBD-CFA) was detected fluorimetrically at 556nm with an excitation wavelength of 430nm. Cefotaxime sodium was used as internal standard.
4.Development and Validation of RP-HPLC Method for Simultaneous Estimation of Cefpodoxime Proxetil and Dicloxacillin Sodium in Tablets.
Acharya DR1, Patel DB. Indian J Pharm Sci. 2013 Jan;75(1):31-5. doi: 10.4103/0250-474X.113538.
A simple, accurate, rapid and precise reversed-phase high-performance liquid chromatographic method has been developed and validated for simultaneous determination of cefpodoxime proxetil and dicloxacillin sodium in tablet. The chromatographic separation was carried out on kromasil C18 analytical column (250×4.6 mm; 5 μm) with a mixture of acetonitrile:methanol:trifloroacetic acid (0.001%) with pH 6.5 (30:50:20, v/v/v) as mobile phase; at a flow rate of 1.0 ml/min. UV detection was performed at 235 nm. The dicloxacillin sodium and cefpodoxime proxetil were eluted at 1.92 and 3.35 min, respectively. The peaks were eluted with better resolution. Calibration plots were linear over the concentration range 0.5-20 μg/ml for cefpodoxime proxetil (r(2)=0.9996) and 5-50 μg/ml for dicloxacillin sodium (r(2)=0.9987). The method was validated for accuracy, precision, linearity and specificity. The method was very sensitive with limit of detection 0.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Antibacterial Products


CAS 22189-32-8 Spectinomycin Dihydrochloride Pentahydrate

Spectinomycin Dihydrochloride Pentahydra
(CAS: 22189-32-8)

The dihydrochloride pentahydrate salt form of Spectinomycin, a derivative of streptomyces spectabilis, has been found to be effective against gram-negative bact...

CAS 14222-60-7 Prothionamide

Prothionamide
(CAS: 14222-60-7)

An anti-tuberculosis agent. It has also been used to treat Leprosy. Antibacterial (tuberculostatic).

CAS 68401-82-1 Ceftizoxime sodium

Ceftizoxime sodium
(CAS: 68401-82-1)

A semisynthetic cephalosporin antibiotic for the treatment of infections due to susceptible strains of microorganisms.

CAS 131-69-1 Phthalylsulfacetamide

Phthalylsulfacetamide
(CAS: 131-69-1)

Phthalylsulfacetamide, a sulfanilamide derivative, is a predrug of sulfacetamide and could be used as an antibacterial agent.

CAS 1071638-38-4 MAC13243

MAC13243
(CAS: 1071638-38-4)

MAC13243, an antibacterial agent, is a likely inhibitor of the bacterial lipoprotein targeting chaperone, LolA.

CAS 5854-93-3 Alanosine

Alanosine
(CAS: 5854-93-3)

Alanosine, also known as L-alanosine, is an antitumor antibiotic substance from the fermentation of Streptomyces alanosinicus. L-Alanosine inhibits adenylosucci...

CAS 112811-59-3 Gatifloxacin

Gatifloxacin
(CAS: 112811-59-3)

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, and inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

CAS 66309-69-1 Cefotiam Dihydrochloride

Cefotiam Dihydrochloride
(CAS: 66309-69-1)

Cefotiam hydrochloride is a third generation beta-lactam cephalosporin antibiotic for treatment of severe infections caused by susceptible bacteria.

CAS 113981-44-5 Cefozopran hydrochloride

Cefozopran hydrochloride
(CAS: 113981-44-5)

Cefozopran HCl is a fourth-generation cephalosporin.

CAS 61270-78-8 Cefonicid sodium

Cefonicid sodium
(CAS: 61270-78-8)

Cefonicid sodium is a broadspectrum cephalosporin antibiotic which can be detected using adsorptive square-wave stripping voltammetry.

CAS 74-55-5 Ethambutol

Ethambutol
(CAS: 74-55-5)

Ethambutol is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases. lt directly affects tw...

CAS 4697-36-3 Carbenicillin

Carbenicillin
(CAS: 4697-36-3)

Carbenicillin is broad-spectrum semisynthetic penicillin derivative used parenterally. It is a semi-synthetic penicillin antibiotic which interferes with cell w...

CAS 37321-09-8 Apramycin

Apramycin
(CAS: 37321-09-8)

Apramycin stands out among aminoglycosides for its mechanism of action which is based on blocking translocation and its ability to bind also to the eukaryotic d...

CAS 64953-12-4 Latamoxef sodium

Latamoxef sodium
(CAS: 64953-12-4)

Latamoxef sodium, a broad- spectrum beta-lactam antibiotic, inhibits most commonly occurring gram positive, gram negative, and anaerobic bacteria, it is ineffec...

Kasugamycin hydrochloride hydrate
(CAS: 200132-83-8)

Kasugamycin, an aminoglycosidic antibiotic, inhibits protein synthesis by interacting with the 30S ribosomal subunit. The mechanism of inhibition of protein syn...

CAS 53994-73-3 Cefaclor

Cefaclor
(CAS: 53994-73-3)

Cefaclor is a second-generation cephalosporin antibiotic used to treat some infections caused by bacteria such as pneumonia

CAS 15176-29-1 Edoxudine

Edoxudine
(CAS: 15176-29-1)

Edoxudine, synthesised via organopalladium intermediates, is an antiviral drug.

CAS 1672-88-4 Furagin

Furagin
(CAS: 1672-88-4)

Furagin (a nitrofurantoin analog) has the same efficacy in treating acute cystitis as Ciprofloxacin, however the duration of therapy is longer. Antibacterial.

CAS 74011-58-8 Enoxacin

Enoxacin
(CAS: 74011-58-8)

Enoxacin is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea. Insomnia is a common adv...

CAS 1192500-31-4 Avibactam free acid

Avibactam free acid
(CAS: 1192500-31-4)

Avibactam is a novel investigational non-beta-lactam beta-lactamase inhibitor that is being developed for possible use in combination with ceftaroline in the U....

Chemical Structure

CAS 87239-81-4 Cefpodoxime Proxetil

Quick Inquiry

Verification code

Featured Items